Evidence map›Paper›PMID 34491516›Full record

ArticleNeurochemical research2022

κ-Carrageenan Oligosaccharides Inhibit the Inflammation of Lipopolysaccharide-Activated Microglia Via TLR4/NF-κB and p38/JNK MAPKs Pathways.

Zi-Ang Yao, Ling Xu, Li-Ming Jin, Bai-Xiang Wang, Cheng-Zhu Fu, Ying Bai, Hai-Ge Wu

Abstract read
PubMed Publisher
In one paragraph

Article in Neurochemical research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Frontiers in veterinary science · 2025
    Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Zi-Ang Yao *College of Life Science, Dalian Minzu University, Dalian, 116600, Liaoning, China.
Ling Xu *Department of Clinical Laboratory, Xinhua Hospital Affiliated to Dalian University, Dalian, 116021, Liaoning, China.ORCID http://orcid.org/0000-0002-6085-0563
Li-Ming JinCollege of Life Science, Dalian Minzu University, Dalian, 116600, Liaoning, China.
Bai-Xiang WangCollege of Life Science and Technology, Dalian University, No. 10 Xuefu Street, Dalian Economic and Technological Development Zone, Dalian, 116622, Liaoning, China.
Cheng-Zhu FuCollege of Life Science and Technology, Dalian University, No. 10 Xuefu Street, Dalian Economic and Technological Development Zone, Dalian, 116622, Liaoning, China.
Ying BaiDepartment of Clinical Laboratory, Xinhua Hospital Affiliated to Dalian University, Dalian, 116021, Liaoning, China.
Hai-Ge WuCollege of Life Science and Technology, Dalian University, No. 10 Xuefu Street, Dalian Economic and Technological Development Zone, Dalian, 116622, Liaoning, China. haige-hu@163.com.
Dalian University · CNDalian Minzu University · CNDalian University of Technology · CN

Funding

Dalian High-level Talents Innovation Support Program 2018RQ54Open Fund of Key Laboratory of Biotechnology and Bioresources Utilization (Dalian Minzu University), and Ministry of Education NO. KF2018006the National Natural Science Funds of China 81671243
6 · The paper itself

Abstract

Microglial inflammation plays an essential role in neurodegenerative disease. Our previous studies had shown that κ-carrageenan oligosaccharides (KOS) could inhibit the excessive activation of microglia that induced by LPS, while the interrelated mechanisms were still indistinct. Therefore, we detected the inflammatory signaling pathway on LPS-activated microglia that pretreat by different content of KOS to reveal the mechanism on KOS's inhibition of microglia inflammatory response. ELISA was used to detect the effects of KOS on the secretion of interleukin-1 (IL-1β), tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) and prostaglandin E2 (PG-2) by LPS-activated microglia, respectively. The production of reactive oxygen species (ROS) and nitric oxide (NO) in microglia cells was detected by flow cytometry, and the protein expression of immunoinflammation-related signaling pathways were detected by Western Blot. The results showed that KOS could significantly protected the microglia from the over-activated inflammatory by inhibiting the release of inflammatory cytokines and the oxidative stress response. And KOS could reduce the expression of the protein that related to the TLR4/NF-κB and p38/JNK MAPKs pathways activated by LPS in microglia. However, there may be no specific target of KOS in cells. Therefore, KOS, a natural algal source oligosaccharide, has immunomodulatory effects and can be used as a potential intervention therapy for inflammatory related neurodegenerative diseases.

Indexed as

LipopolysaccharidesNeurodegenerative DiseasesCarrageenanHumansInflammationMicrogliaNF-kappa BNitric OxideNitric Oxide Synthase Type IIOligosaccharidesp38 Mitogen-Activated Protein KinasesToll-Like Receptor 4CarrageenanLipopolysaccharidesNF-kappa BNitric OxideNitric Oxide Synthase Type IIOligosaccharidesp38 Mitogen-Activated Protein KinasesTLR4 protein, humanToll-Like Receptor 4InflammationMicrogliaSignaling pathwayκ-Carrageenan oligosaccharides

Identifiers

PMID34491516
OpenAlexW3198383842

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.